Metformin‐Mediated Glycaemic Regulation as a Potential Strategy for Breast Cancer Prevention

Key Points

• Metformin may influence anti-cancer biochemical pathways, which could help in breast cancer prevention.
• The potential for metformin as an anti-cancer therapeutic is supported by its effects on glycaemic regulation.
• Analysis indicates a link between glycaemic regulation and reduced breast cancer risk with metformin.
• These findings suggest further investigation into metformin's role in cancer prevention is warranted.

Abstract